Asia-Pacific (APAC) Orthobiologic Procedures Count by Segments and Forecast to 2030

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$3995
Buy Report Download FREE Resources

Published: January 13, 2023 Report Code: GDMEPD1216R17-ST

Select Item

APAC Orthobiologic Procedures Market Report Overview

The total number of Orthobiologic Procedures conducted in APAC was 3,924,645 in 2022. The following are some of the key highlights of the APAC Orthobiologic Procedures market:

  • Orthobiologic Procedures are used to improve the healing of fractured bones and injured muscles, tendons, and ligaments, and are derived from substances that are naturally found in the body.
  • Orthobiologics that contain stem cells are those that likely work through their stem cell content.
  • Viscosupplementation Procedures were the most performed Orthobiologic Procedures in 2022 in APAC.
  • Japan was the leading country in terms of the number of Orthobiologic Procedures conducted in APAC in 2022.

APAC Orthobiologic Procedures Market Outlook 2015-2030 (Number of Procedures)
APAC Orthobiologic Procedures Market Outlook 2015-2030 (Number of Procedures)
Buy the Full Report for More Insights on the APAC Orthobiologic Procedures Market Forecast, Download a Free Sample Report

The APAC Orthobiologic Procedures market research report is a comprehensive databook report covering key procedures data on the Asia-Pacific Orthobiologic Procedures. It also provides procedure volumes within segments from 2015 to 2030.

Market Size (2022) 3,924,645 Procedures
Forecast Period 2023-2030
Historical Period 2015-2022
Key Segments ·        Viscosupplementation Procedures

·        Bone Grafts and Substitutes Procedures

·        Soft Tissue Biologics Procedures

·        Cartilage Repair Procedures

·        Bone Growth Stimulators Procedures
Key Countries ·        Australia

·        China

·        India

·        Japan

·        South Korea
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

APAC Orthobiologic Procedures Market Segments

The key segments in the APAC Orthobiologic Procedures market are Viscosupplementation Procedures, Bone Grafts and Substitutes Procedures, Soft Tissue Biologics Procedures, Cartilage Repair Procedures, and Bone Growth Stimulators Procedures.

Viscosupplementation Procedures: Viscosupplementation procedure involves the replacement of synovial fluid at the joints by a Hyaluronate preparation which has viscous properties similar to the natural synovial fluid. Viscosupplementation Procedure is used for the treatment of osteoarthritis of knee and other joints. Other joints include hip, shoulder, ankle, elbow, wrist, hand, and foot.

APAC Orthobiologic Procedures Market Analysis by Segments, 2022 (%)
APAC Orthobiologic Procedures Market Analysis by Segments, 2022 (%)
Buy the Full Report for Insights into the APAC Orthobiologic Procedures Market Segments, Download a Free Report Sample

APAC Orthobiologic Procedures Market Segmentation by Countries

The countries covered in the APAC Orthobiologic Procedures market are Australia, China, India, Japan, and South Korea.

APAC Orthobiologic Procedures Market Analysis by Countries, 2022 (%)
APAC Orthobiologic Procedures Market Analysis by Countries, 2022 (%)Buy the Full Report for Country-Wise Insights into the APAC Orthobiologic Procedures market, Download a Free Report Sample

APAC Orthobiologic Procedures Market Report Overview

Segments Covered in the Report

APAC Orthobiologic Procedures Market Segments Outlook (Number of Procedures, 2015-2030)

  • Viscosupplementation Procedures
  • Bone Grafts and Substitutes Procedures
  • Soft Tissue Biologics Procedures
  • Cartilage Repair Procedures
  • Bone Growth Stimulators Procedures

APAC Orthobiologic Procedures Market Countries Outlook (Number of Procedures, 2015-2030)

  • Australia
  • China
  • India
  • Japan
  • South Korea

Reasons to Buy

The Asia-Pacific Orthobiologic Procedures report helps you to develop:

  • Business strategies by identifying the key segments poised for strong growth in the future.

  • Market-entry and market expansion strategies.

  • Develop investment strategies by identifying the key segments expected to register strong growth in the near future.

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables

    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 What Is This Report About?

    • 2.2 Orthobiologic Procedures, Segmentation

    • 2.3 Definitions of Procedures Covered in the Report

  • 3 Orthobiologic Procedures, Asia-Pacific

    • 3.1 Orthobiologic Procedures, Asia-Pacific, 2015-2030

    • 3.2 Orthobiologic Procedures, Asia-Pacific, 2015-2022

  • 4 Orthobiologic Procedures, Australia

    • 4.1 Orthobiologic Procedures, Australia, 2015-2030

      • 4.1.1 Bone Grafts and Substitutes Procedures, Australia, 2015-2030

      • 4.1.2 Bone Growth Stimulators Procedures, Australia, 2015-2030

      • 4.1.3 Cartilage Repair Procedures, Australia, 2015-2030

      • 4.1.4 Soft Tissue Biologics Procedures, Australia, 2015-2030

  • 5 Orthobiologic Procedures, China

    • 5.1 Orthobiologic Procedures, China, 2015-2030

      • 5.1.1 Bone Grafts and Substitutes Procedures, China, 2015-2030

      • 5.1.2 Bone Growth Stimulators Procedures, China, 2015-2030

      • 5.1.3 Cartilage Repair Procedures, China, 2015-2030

      • 5.1.4 Soft Tissue Biologics Procedures, China, 2015-2030

  • 6 Orthobiologic Procedures, India

    • 6.1 Orthobiologic Procedures, India, 2015-2030

      • 6.1.1 Bone Grafts and Substitutes Procedures, India, 2015-2030

      • 6.1.2 Bone Growth Stimulators Procedures, India, 2015-2030

      • 6.1.3 Cartilage Repair Procedures, India, 2015-2030

      • 6.1.4 Soft Tissue Biologics Procedures, India, 2015-2030

  • 7 Orthobiologic Procedures, Japan

    • 7.1 Orthobiologic Procedures, Japan, 2015-2030

      • 7.1.1 Bone Grafts and Substitutes Procedures, Japan, 2015-2030

      • 7.1.2 Bone Growth Stimulators Procedures, Japan, 2015-2030

      • 7.1.3 Cartilage Repair Procedures, Japan, 2015-2030

      • 7.1.4 Soft Tissue Biologics Procedures, Japan, 2015-2030

  • 8 Orthobiologic Procedures, South Korea

    • 8.1 Orthobiologic Procedures, South Korea, 2015-2030

      • 8.1.1 Bone Grafts and Substitutes Procedures, South Korea, 2015-2030

      • 8.1.2 Bone Growth Stimulators Procedures, South Korea, 2015-2030

      • 8.1.3 Cartilage Repair Procedures, South Korea, 2015-2030

      • 8.1.4 Soft Tissue Biologics Procedures, South Korea, 2015-2030

  • 9 Appendix

    • 9.1 Research Methodology

      • 9.1.1 Coverage

      • 9.1.2 Secondary Research

      • 9.1.3 Primary Research

      • 9.1.4 Market Modeling and Forecasting

      • 9.1.5 Company Share Analysis

      • 9.1.6 Distribution Share Analysis

      • 9.1.7 Benchmarking

    • 9.2 GlobalData Consulting

    • 9.3 Contact Us

    • 9.4 Disclaimer

Table

List of Tables

Table 1: Orthobiologic Procedures, Asia-Pacific, 2015-2030 11

Table 2: Orthobiologic Procedures, Asia-Pacific, 2015-2022 13

Table 3: Orthobiologic Procedures, Asia-Pacific, 2023-2030 15

Table 4: Orthobiologic Procedures, Australia, 2015-2022 17

Table 5: Orthobiologic Procedures, Australia, 2023-2030 19

Table 6: Bone Grafts and Substitutes Procedures, Australia, 2015-2022 21

Table 7: Bone Grafts and Substitutes Procedures, Australia, 2023-2030 23

Table 8: Bone Growth Stimulators Procedures, Australia, 2015-2022 25

Table 9: Bone Growth Stimulators Procedures, Australia, 2023-2030 27

Table 10: Cartilage Repair Procedures, Australia, 2015-2022 29

Table 11: Cartilage Repair Procedures, Australia, 2023-2030 31

Table 12: Soft Tissue Biologics Procedures, Australia, 2015-2022 33

Table 13: Soft Tissue Biologics Procedures, Australia, 2023-2030 35

Table 14: Orthobiologic Procedures, China, 2015-2022 37

Table 15: Orthobiologic Procedures, China, 2023-2030 39

Table 16: Bone Grafts and Substitutes Procedures, China, 2015-2022 41

Table 17: Bone Grafts and Substitutes Procedures, China, 2023-2030 43

Table 18: Bone Growth Stimulators Procedures, China, 2015-2022 45

Table 19: Bone Growth Stimulators Procedures, China, 2023-2030 47

Table 20: Cartilage Repair Procedures, China, 2015-2022 49

Table 21: Cartilage Repair Procedures, China, 2023-2030 51

Table 22: Soft Tissue Biologics Procedures, China, 2015-2022 53

Table 23: Soft Tissue Biologics Procedures, China, 2023-2030 55

Table 24: Orthobiologic Procedures, India, 2015-2022 57

Table 25: Orthobiologic Procedures, India, 2023-2030 59

Table 26: Bone Grafts and Substitutes Procedures, India, 2015-2022 61

Table 27: Bone Grafts and Substitutes Procedures, India, 2023-2030 63

Table 28: Bone Growth Stimulators Procedures, India, 2015-2022 65

Table 29: Bone Growth Stimulators Procedures, India, 2023-2030 67

Table 30: Cartilage Repair Procedures, India, 2015-2022 69

Table 31: Cartilage Repair Procedures, India, 2023-2030 71

Table 32: Soft Tissue Biologics Procedures, India, 2015-2022 73

Table 33: Soft Tissue Biologics Procedures, India, 2023-2030 75

Table 34: Orthobiologic Procedures, Japan, 2015-2022 77

Table 35: Orthobiologic Procedures, Japan, 2023-2030 79

Table 36: Bone Grafts and Substitutes Procedures, Japan, 2015-2022 81

Table 37: Bone Grafts and Substitutes Procedures, Japan, 2023-2030 83

Table 38: Bone Growth Stimulators Procedures, Japan, 2015-2022 85

Table 39: Bone Growth Stimulators Procedures, Japan, 2023-2030 87

Table 40: Cartilage Repair Procedures, Japan, 2015-2022 89

Table 41: Cartilage Repair Procedures, Japan, 2023-2030 91

Table 42: Soft Tissue Biologics Procedures, Japan, 2015-2022 93

Table 43: Soft Tissue Biologics Procedures, Japan, 2023-2030 95

Table 44: Orthobiologic Procedures, South Korea, 2015-2022 97

Table 45: Orthobiologic Procedures, South Korea, 2023-2030 99

Table 46: Bone Grafts and Substitutes Procedures, South Korea, 2015-2022 101

Table 47: Bone Grafts and Substitutes Procedures, South Korea, 2023-2030 103

Table 48: Bone Growth Stimulators Procedures, South Korea, 2015-2022 105

Table 49: Bone Growth Stimulators Procedures, South Korea, 2023-2030 107

Table 50: Cartilage Repair Procedures, South Korea, 2015-2022 109

Table 51: Cartilage Repair Procedures, South Korea, 2023-2030 111

Table 52: Soft Tissue Biologics Procedures, South Korea, 2015-2022 113

Table 53: Soft Tissue Biologics Procedures, South Korea, 2023-2030 115

Table 54: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 118

Figures

List of Figures

Figure 1: Orthobiologic Procedures, Asia-Pacific, 2015-2030 10

Figure 2: Orthobiologic Procedures, Asia-Pacific, 2015-2022 12

Figure 3: Orthobiologic Procedures, Asia-Pacific, 2023-2030 14

Figure 4: Orthobiologic Procedures, Australia, 2015-2022 16

Figure 5: Orthobiologic Procedures, Australia, 2023-2030 18

Figure 6: Bone Grafts and Substitutes Procedures, Australia, 2015-2022 20

Figure 7: Bone Grafts and Substitutes Procedures, Australia, 2023-2030 22

Figure 8: Bone Growth Stimulators Procedures, Australia, 2015-2022 24

Figure 9: Bone Growth Stimulators Procedures, Australia, 2023-2030 26

Figure 10: Cartilage Repair Procedures, Australia, 2015-2022 28

Figure 11: Cartilage Repair Procedures, Australia, 2023-2030 30

Figure 12: Soft Tissue Biologics Procedures, Australia, 2015-2022 32

Figure 13: Soft Tissue Biologics Procedures, Australia, 2023-2030 34

Figure 14: Orthobiologic Procedures, China, 2015-2022 36

Figure 15: Orthobiologic Procedures, China, 2023-2030 38

Figure 16: Bone Grafts and Substitutes Procedures, China, 2015-2022 40

Figure 17: Bone Grafts and Substitutes Procedures, China, 2023-2030 42

Figure 18: Bone Growth Stimulators Procedures, China, 2015-2022 44

Figure 19: Bone Growth Stimulators Procedures, China, 2023-2030 46

Figure 20: Cartilage Repair Procedures, China, 2015-2022 48

Figure 21: Cartilage Repair Procedures, China, 2023-2030 50

Figure 22: Soft Tissue Biologics Procedures, China, 2015-2022 52

Figure 23: Soft Tissue Biologics Procedures, China, 2023-2030 54

Figure 24: Orthobiologic Procedures, India, 2015-2022 56

Figure 25: Orthobiologic Procedures, India, 2023-2030 58

Figure 26: Bone Grafts and Substitutes Procedures, India, 2015-2022 60

Figure 27: Bone Grafts and Substitutes Procedures, India, 2023-2030 62

Figure 28: Bone Growth Stimulators Procedures, India, 2015-2022 64

Figure 29: Bone Growth Stimulators Procedures, India, 2023-2030 66

Figure 30: Cartilage Repair Procedures, India, 2015-2022 68

Figure 31: Cartilage Repair Procedures, India, 2023-2030 70

Figure 32: Soft Tissue Biologics Procedures, India, 2015-2022 72

Figure 33: Soft Tissue Biologics Procedures, India, 2023-2030 74

Figure 34: Orthobiologic Procedures, Japan, 2015-2022 76

Figure 35: Orthobiologic Procedures, Japan, 2023-2030 78

Figure 36: Bone Grafts and Substitutes Procedures, Japan, 2015-2022 80

Figure 37: Bone Grafts and Substitutes Procedures, Japan, 2023-2030 82

Figure 38: Bone Growth Stimulators Procedures, Japan, 2015-2022 84

Figure 39: Bone Growth Stimulators Procedures, Japan, 2023-2030 86

Figure 40: Cartilage Repair Procedures, Japan, 2015-2022 88

Figure 41: Cartilage Repair Procedures, Japan, 2023-2030 90

Figure 42: Soft Tissue Biologics Procedures, Japan, 2015-2022 92

Figure 43: Soft Tissue Biologics Procedures, Japan, 2023-2030 94

Figure 44: Orthobiologic Procedures, South Korea, 2015-2022 96

Figure 45: Orthobiologic Procedures, South Korea, 2023-2030 98

Figure 46: Bone Grafts and Substitutes Procedures, South Korea, 2015-2022 100

Figure 47: Bone Grafts and Substitutes Procedures, South Korea, 2023-2030 102

Figure 48: Bone Growth Stimulators Procedures, South Korea, 2015-2022 104

Figure 49: Bone Growth Stimulators Procedures, South Korea, 2023-2030 106

Figure 50: Cartilage Repair Procedures, South Korea, 2015-2022 108

Figure 51: Cartilage Repair Procedures, South Korea, 2023-2030 110

Figure 52: Soft Tissue Biologics Procedures, South Korea, 2015-2022 112

Figure 53: Soft Tissue Biologics Procedures, South Korea, 2023-2030 114

Frequently asked questions

Asia-Pacific (APAC) Orthobiologic Procedures Count by Segments and Forecast to 2030 standard reports
Currency USD
$3,995

Can be used by individual purchaser only

Most Popular
$7,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$11,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Asia-Pacific (APAC) Orthobiologic Procedures Count by Segments and Forecast to 2030 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Orthobiologics reports
Medical Devices
New
Clostridium Difficile Tests Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | May 2026
Medical Devices
New
Cholesterol Tests Market Size by Segments, Share, Regulatory, Reimbursement, and…
$7,500 | May 2026
Medical Devices
New
Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | May 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Asia-Pacific (APAC) Orthobiologic Procedures Count by Segments and Forecast to 2030 in real time.

  • Access a live Asia-Pacific (APAC) Orthobiologic Procedures Count by Segments and Forecast to 2030 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more